Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
EPHB4-associated vascular malformation spectrum
Mode Of Inheritance:
Autosomal dominant
Evaluated Date:
11/03/2022
Evidence/Notes:

Ephrin Receptor EphB4 (EPHB4; MIM#600011) is a receptor tyrosine kinase transmembrane protein that has a critical role in angiogenesis and vascular development. Regulation is complex with bidirectional signaling critical for vasculature assembly and mesenchymal cell differentiation. Autosomal dominant pathogenic variants in EPHB4 were first described in 2016 (PMID:28687708, 27400125) in association with variable vascular malformations including capillary and arteriovenous malformations (CM-AVM), and has since been described in many additional affected individuals with phenotypes including CM-AVMs, lymphatic malformations, non-immune hydrops fetalis, recurrent epistaxis and additional vascular and lymphatic phenotypes (PMID:33864021, 27400125, 29444212, others). The phenotype of EPHB4 has high intra- and interfamilial variability (PMID:33864021, 27400125) and can be associated with a spectrum of phenotypes ranging from subtle features of lymphatic dysfunction to lethal non-immune hydrops fetalis. The mechanism is loss of function, and while nonsense and frameshift variants are found throughout the coding sequence, pathogenic missense variants are found to be enriched within the Tyrosine Kinase domain (for Review; PMID:30819650) Animal models of EPHB4 demonstrate defects in vascular modeling, growth restriction, pre- and postnatal edemas, and tortuous dilated lymphatic vessels (PMID:10518221, 27400125, 29444212). EPHB4 is curated by the Prenatal Gene Curation Expert Panel as Definitive for EPHB4-associated vascular malformation spectrum.

PubMed IDs:
9990854 10518221 12039842 25247423 27400125 28687708 29444212
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.